AI assistant
Sending…
PFIZER INC — Director's Dealing 2020
Feb 26, 2020
29831_dirs_2020-02-25_4bd44bd2-4428-4d49-ace4-a2b816009310.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2020-02-23
Reporting Person: ROGERS DAWN (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-23 | Common Stock | F | 1015.0000 | $35.7200 | Disposed | 9898.0000 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 9032.0000 | Indirect |
Footnotes
F1: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).
F2: Price is the closing price of Pfizer common stock on February 21, 2020.
More from PFIZER INC
Major Shareholding Notification
2026
May 12
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 5
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
May 1
Regulatory Filings
2026
Apr 27
Director's Dealing
2026
Mar 31
Director's Dealing
2026
Mar 31
Director's Dealing
2026
Mar 31